Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy

doi:10.4254/wjh.v7.i7.926

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (17355)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

1992

WORD

423

HTML

11847

Figures (1-1)

276

Tables (1-5)

233

Sum=14771

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1141

Download

1443

Sum=2584

May 8, 2015 (publication date) through Nov 12, 2024

Times Cited of This Article

Times Cited (80)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. May 8, 2015; 7(7): 926-941
Published online May 8, 2015. doi: 10.4254/wjh.v7.i7.926

Table 4 Drugs without efficacy in primary biliary cirrhosis as demonstrated in clinical trials

Drug	Ref.
Azathioprine	[106]
Chlorambucil	[107]
Methotrexate	[108-110]
Mycophenolate mofetil	[111]
Cyclosporine	[112]
Penicillamine	[113,114]
Colchicine	[115,116]
Malotilate	[117]
Thalidomide	[118]
Silymarin	[119]
Statins	[120]

Citation: Purohit T, Cappell MS. Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy. World J Hepatol 2015; 7(7): 926-941
URL: https://www.wjgnet.com/1948-5182/full/v7/i7/926.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i7.926